Hamidreza Iranmanesh, MD
NPI 1710189097 · Hospitalist Physician · Kingwood, TX
Enrolled with Medicare as Practitioner - Hospitalist · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1710189097
- Entity type
- Individual
- Primary specialty
- Hospitalist PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- N3749 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,778 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 501 | $14 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 328 | $91 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 243 | $123 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 142 | $128 |
| Detection Test By Immunoassay With Direct Visual Observation for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)87811 | 93 | $41 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Azithromycin | 239 | 208 |
| Prednisone | 211 | 186 |
| Cefdinir | 169 | 150 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 102 | 97 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 100 | 88 |
| Ciprofloxacin Hcl | 57 | 56 |
| Mupirocin | 54 | 53 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$100 across 5 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-05-31
- Last updated
- 2024-09-17
- Certified
- 2024-09-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.